The clinical trial evidence on duration The landmark STEP trials for semaglutide and SURMOUNT trials for tirzepatide provide the clearest data on what happens at different treatment durations
People who are most likely to benefit from a GLP-1 RA are sometimes the least likely [archived link] to have access to them
For these and all other chronic conditions, patients, and society in general, understand that without continuous treatment, their disease will not be well controlled and lead to complication, Hurtado told Healthline
This article examines the safety considerations, potential risks, and evidence-based alternatives for postpartum weight management that protect both maternal and infant health
Take the quiz Complete a 2 minute health assessment to get pre-approved for treatment instantly
Losing weight without the assistance of drugs or other medical interventions can look different to doing so using glucagon-like peptide-1 (GLP-1) receptor agonists